Prestwich Pharmacy Limited - Abbreviated accounts 16.1

Prestwich Pharmacy Limited - Abbreviated accounts 16.1


04934939 1.12.14 30.11.15 30.11.15 Company accounts Private Limited Company FY true false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 Ordinary E 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure049349392014-11-30049349392015-11-30049349392014-12-012015-11-30049349392013-10-31049349392013-11-012014-11-30049349392014-11-3004934939ns12:England2014-12-012015-11-3004934939ns14:PoundSterling2014-12-012015-11-3004934939ns7:Director12014-12-012015-11-3004934939ns7:OrdinaryShareClass12014-12-012015-11-3004934939ns7:OrdinaryShareClass22014-12-012015-11-3004934939ns7:OrdinaryShareClass32014-12-012015-11-3004934939ns7:OrdinaryShareClass42014-12-012015-11-3004934939ns7:OrdinaryShareClass52014-12-012015-11-3004934939ns7:Director22014-12-012015-11-3004934939ns7:Director32014-12-012015-11-3004934939ns7:Director42014-12-012015-11-3004934939ns7:CompanySecretary2014-12-012015-11-3004934939ns7:RegisteredOffice2014-12-012015-11-3004934939ns7:EntityAccountantsOrAuditors2014-12-012015-11-3004934939ns7:EntityBankers2014-12-012015-11-3004934939ns5:ImprovementsOrDevelopmentAssets2014-12-012015-11-3004934939ns5:PlantMachinery2014-12-012015-11-3004934939ns5:FixturesFittings2014-12-012015-11-3004934939ns5:FixedAssetInvestmentsOtherThanLoans2015-11-3004934939ns5:FixedAssetInvestmentsOtherThanLoans2014-11-3004934939ns5:Subsidiary12014-12-012015-11-3004934939ns5:Subsidiary12013-11-012014-11-3004934939ns7:OrdinaryShareClass12015-11-3004934939ns7:OrdinaryShareClass12014-11-3004934939ns7:OrdinaryShareClass22015-11-3004934939ns7:OrdinaryShareClass22014-11-3004934939ns7:OrdinaryShareClass32015-11-3004934939ns7:OrdinaryShareClass32014-11-3004934939ns7:OrdinaryShareClass42015-11-3004934939ns7:OrdinaryShareClass42014-11-3004934939ns7:OrdinaryShareClass52015-11-3004934939ns7:OrdinaryShareClass52014-11-30
REGISTERED NUMBER: 04934939 (England and Wales)















Abbreviated Unaudited Accounts for the Year Ended 30 November 2015

for

PRESTWICH PHARMACY LIMITED

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Contents of the Abbreviated Accounts
for the Year Ended 30 November 2015










Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

PRESTWICH PHARMACY LIMITED

Company Information
for the Year Ended 30 November 2015







DIRECTORS: Mr F G McCaul M.R.Pharm.S
Mr H Hughes M.R.Pharm.S
Mrs H Hughes M.R.Pharm.S
Mr M Williams M.R.Pharm.S



SECRETARY: Mr H Hughes M.R.Pharm.S



REGISTERED OFFICE: Century Buildings
14 St Mary's Parsonage
Manchester
M3 2DF



REGISTERED NUMBER: 04934939 (England and Wales)



ACCOUNTANTS: BTMR Limited
Century Buildings
14 St Mary's Parsonage
Manchester
M3 2DF



BANKERS: Lloyds TSB Bank Plc
Burnley Branch
Burnley
Lancashire

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Abbreviated Balance Sheet
30 November 2015

30.11.15 30.11.14
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 62,046 120,420
Investments 3 162,981 162,981
225,027 283,401

CURRENT ASSETS
Stocks 171,698 187,552
Debtors 303,444 349,649
Prepayments and accrued income 9,761 20,838
Cash at bank and in hand 10,430 18,271
495,333 576,310
CREDITORS
Amounts falling due within one year 581,814 638,157
NET CURRENT LIABILITIES (86,481 ) (61,847 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

138,546

221,554

CREDITORS
Amounts falling due after more than one year - 95,119
NET ASSETS 138,546 126,435

CAPITAL AND RESERVES
Called up share capital 4 10,004 10,004
Share premium 92,668 92,668
Profit and loss account 35,874 23,763
SHAREHOLDERS' FUNDS 138,546 126,435

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 25 May 2016 and were signed on its behalf by:



Mr F G McCaul M.R.Pharm.S - Director


PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Abbreviated Accounts
for the Year Ended 30 November 2015


1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective January 2015).

Turnover
Turnover is accounted for as revenue when, and to the extent that, the company obtains a right to consideration
in exchange for its performance of its obligations under the sales contract with the customer. The amount
reported as revenue is the fair value of the right to consideration - usually the price specified in the contractual
arrangement net of discounts and net of VAT, and after any allowance for credit risk and other uncertainties.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Improvements to property - 10% on cost
Plant and machinery - 33% on cost and 10% on cost
Fixtures and fittings - 50% on cost and 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual
arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any
contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Government grants
Deferred government grants in respect of capital expenditure are treated as deferred income and are credited to
the profit and loss account over the estimated useful life of the assets to which they relate.

Government grants in respect of overhead expenditure are matched against the overhead incurred.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 December 2014 1,011,493
Additions 30,629
At 30 November 2015 1,042,122
DEPRECIATION
At 1 December 2014 891,073
Charge for year 89,003
At 30 November 2015 980,076
NET BOOK VALUE
At 30 November 2015 62,046
At 30 November 2014 120,420

PRESTWICH PHARMACY LIMITED (REGISTERED NUMBER: 04934939)

Notes to the Abbreviated Accounts - continued
for the Year Ended 30 November 2015


3. FIXED ASSET INVESTMENTS
Investments
other
than
loans
£   
COST
At 1 December 2014
and 30 November 2015 162,981
NET BOOK VALUE
At 30 November 2015 162,981
At 30 November 2014 162,981

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Hughes McCaul Limited
Nature of business: Dormant company
%
Class of shares: holding
Ordinary shares of £1 each 100.00
30.11.15 30.11.14
£    £   
Aggregate capital and reserves 255,649 255,649

The investment represents the purchase of 100% of the issued ordinary share capital of Hughes McCaul Limited,
a company incorporated in England and Wales. The shares purchased are 600,100 ordinary shares of £1 each.

Consolidated accounts for the group have not been prepared on the grounds that the group qualifies as a small
group under the Companies Act 2006.

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.11.15 30.11.14
value: £    £   
10,000 Ordinary A £1 10,000 10,000
1 Ordinary B £1 1 1
1 Ordinary C £1 1 1
1 Ordinary D £1 1 1
1 Ordinary E £1 1 1
10,004 10,004